MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Clinical trials for MALIGNANT GENITOURINARY SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT GENITOURINARY SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT GENITOURINARY SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills may soothe Immunotherapy's gut side effects in cancer patients
Symptom relief Recruiting nowThis early-phase study tests whether fecal microbiota transplantation (FMT) can safely reduce severe diarrhea or colon inflammation caused by immune-checkpoint inhibitors in people with genitourinary and other cancers. About 40 participants will receive FMT and be monitored for s…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 16, 2026 22:32 UTC
-
Are surgeons doing enough to prevent blood clots in cancer patients?
Knowledge-focused Recruiting nowThis study surveys surgeons and advanced practice providers to see how often they prescribe extended blood clot prevention after abdominal or pelvic cancer surgery. The goal is to understand current practices and improve guideline use. About 500 participants from the NCORP networ…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 16, 2026 22:28 UTC
-
Poop pills could soothe cancer drug side effects
Knowledge-focused Recruiting nowThis study looks at how the bacteria in your gut might cause stomach issues like diarrhea and colitis when you take certain cancer drugs called immune checkpoint inhibitors. Researchers will collect stool, blood, and tissue samples from 800 people with melanoma, lung, or genitour…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC